Network Modeling Identifies Patient-specific Pathways in Glioblastoma

Area of Science:

• Oncology
• Systems Biology
• Bioinformatics

Background:

• Glioblastoma is a highly aggressive brain tumor characterized by significant molecular heterogeneity.
• This heterogeneity poses a major challenge for developing effective targeted therapies.
• Identifying common or tumor-specific signaling alterations is crucial for treatment development.

Purpose of the Study:

• To investigate if common signaling pathways can be identified in heterogeneous glioblastoma tumors.
• To develop a network-based strategy for identifying hidden therapeutic targets.
• To improve target selection for glioblastoma treatment.

Main Methods:

• Reconstruction of altered signaling pathways using network modeling from phosphoproteomic data and protein-protein interactions.
• Development of a network-based strategy to identify unobserved, predicted targets.
• Analysis of tumor-specific proteins and pathways.

Main Results:

• Network models successfully identified common and tumor-specific pathway-level changes despite proteomic heterogeneity.
• ERK activator kinase1 (MEK1) showed increased phosphorylation in all analyzed glioblastoma tumors.
• Protein numb homolog (NUMB) was found in a subset of invasive tumors, and S100A4 was elevated in only one tumor type.

Conclusions:

• Network modeling is a viable approach to uncover conserved and specific molecular alterations in glioblastoma.
• This strategy can identify potential therapeutic targets, such as MEK1, applicable across diverse glioblastoma subtypes.
• The findings provide a proof of principle for enhancing targeted therapy selection in complex cancers.